| Dr Marian Akamin Nkeng, PHARMD | |
|
15520 Annapolis Rd, Bowie, MD 20715-3002 | |
| (202) 390-6524 | |
| Not Available |
| Full Name | Dr Marian Akamin Nkeng |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 15520 Annapolis Rd, Bowie, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235731662 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 25959 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marian Akamin Nkeng, PHARMD 15520 Annapolis Rd, Bowie, MD 20715-3002 Ph: (202) 390-6524 | Dr Marian Akamin Nkeng, PHARMD 15520 Annapolis Rd, Bowie, MD 20715-3002 Ph: (202) 390-6524 |
News Archive
The continued marketing and use of experimental stem cell-based interventions inside and outside the United States is problematic and unsustainable, according to a new paper by science policy and bioethics experts at Rice University's Baker Institute for Public Policy and Wake Forest University.
According to a recommendation by a federal advisory panel, before newborns leave the hospital, they should receive a simple, pain-free test to check for signs of congenital heart disease, one of the most common types of birth defects.
Lithera, Inc., a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and ophthalmology, announced today that the first patient has been treated with LIPO-202 (Salmeterol Xinafoate for Injection) in its 500-patient Phase 2b "RESET" trial.
Researchers at the University of Colorado Anschutz Medical Campus, working with the National Institutes of Health, will conduct a clinical trial beginning this month to determine if monthly injections of anti-viral drugs are more effective at suppressing the HIV virus than daily pills in a population for whom daily adherence has been a challenge.
FDA put on display today a Federal Register notice seeking public comment on a proposal for withdrawing "essential-use" status for albuterol metered-dose inhalers (MDIs) using chlorofluorocarbon (CFC) propellants.
› Verified 4 days ago
Nita Atabong, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15520 Annapolis Rd, Bowie, MD 20715 Phone: 301-809-3151 | |
William Todd Baker Iii, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15990 Annapolis Rd, Bowie, MD 20715 Phone: 301-352-2340 Fax: 301-352-7407 | |
Deborah T Adedeji, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4600 Mitchellville Rd, Bowie, MD 20716 Phone: 301-352-3847 | |
Beltus Simo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3300 Crain Hwy, Bowie, MD 20716 Phone: 301-805-8853 | |
Mr. Kurtis David Dawley, PHARM-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4600 Mitchellville Rd, Bowie, MD 20716 Phone: 301-352-3847 | |
Janelle Meads, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15520 Annapolis Rd, Bowie, MD 20715 Phone: 301-809-3151 Fax: 844-411-6292 | |
Mr. Charles Michael Bronder Jr., R PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2011 Alban Ln, Bowie, MD 20716 Phone: 301-249-1786 |